← Back to SKYE

Skye Bioscience, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 10/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 10/11/2025Jun 2024Filed 10/11/2025Mar 2024Filed 10/11/2025
−$11−$13−$13−$18−$11−$3.9−$7.9−$5
−$0.27−$0.32−$0.32−$0.44−$0.28−$0.10−$0.20−$0.18
4040404040393928

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.